Livzon Pharmaceutical Group's total assets for Q3 2024 were ¥24.91B, a decrease of -2.61% from the previous quarter. LVZPF total liabilities were ¥9.97B for the fiscal quarter, a -9.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.